Evercore ISI Cuts Henry Schein (NASDAQ:HSIC) Price Target to $70.00

Henry Schein (NASDAQ:HSIC) had its price objective cut by analysts at Evercore ISI from $72.00 to $70.00 in a research note issued to investors on Wednesday, Benzinga reports. The brokerage currently has an “in-line” rating on the stock. Evercore ISI’s target price would indicate a potential upside of 4.71% from the company’s previous close.

A number of other research analysts also recently commented on the company. Robert W. Baird raised Henry Schein from a “neutral” rating to an “outperform” rating and increased their price target for the company from $81.00 to $92.00 in a report on Monday, July 22nd. Barrington Research cut their price objective on Henry Schein from $92.00 to $82.00 and set an “outperform” rating on the stock in a research note on Wednesday. Piper Sandler restated an “overweight” rating and set a $86.00 price objective on shares of Henry Schein in a research note on Friday, June 21st. Baird R W upgraded Henry Schein from a “hold” rating to a “strong-buy” rating in a research note on Monday, July 22nd. Finally, UBS Group cut their price objective on Henry Schein from $82.00 to $80.00 and set a “neutral” rating on the stock in a research note on Wednesday, May 8th. One analyst has rated the stock with a sell rating, six have given a hold rating, six have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $80.67.

Henry Schein Stock Up 4.6 %

HSIC traded up $2.93 on Wednesday, reaching $66.85. The company’s stock had a trading volume of 954,557 shares, compared to its average volume of 1,199,150. The stock has a market cap of $8.56 billion, a price-to-earnings ratio of 22.76, a price-to-earnings-growth ratio of 1.80 and a beta of 0.87. Henry Schein has a 1 year low of $60.01 and a 1 year high of $82.63. The company has a debt-to-equity ratio of 0.47, a current ratio of 1.75 and a quick ratio of 1.02. The business’s 50 day moving average is $67.84 and its 200 day moving average is $71.68.

Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings results on Tuesday, August 6th. The company reported $1.23 EPS for the quarter, beating analysts’ consensus estimates of $1.22 by $0.01. The firm had revenue of $3.10 billion during the quarter, compared to the consensus estimate of $3.27 billion. Henry Schein had a return on equity of 13.51% and a net margin of 3.12%. Henry Schein’s revenue for the quarter was up .0% on a year-over-year basis. During the same quarter in the prior year, the business posted $1.31 earnings per share. As a group, research analysts forecast that Henry Schein will post 5.16 EPS for the current fiscal year.

Institutional Trading of Henry Schein

A number of institutional investors and hedge funds have recently made changes to their positions in the stock. Vanguard Group Inc. raised its position in shares of Henry Schein by 1.7% during the 1st quarter. Vanguard Group Inc. now owns 15,432,001 shares of the company’s stock worth $1,165,425,000 after purchasing an additional 260,537 shares during the period. Swedbank AB acquired a new stake in Henry Schein in the 1st quarter valued at approximately $215,998,000. Boston Partners increased its position in Henry Schein by 144.1% in the 4th quarter. Boston Partners now owns 2,637,429 shares of the company’s stock valued at $199,393,000 after acquiring an additional 1,556,831 shares during the period. Fiduciary Management Inc. WI increased its position in Henry Schein by 17.1% in the 4th quarter. Fiduciary Management Inc. WI now owns 2,284,337 shares of the company’s stock valued at $172,947,000 after acquiring an additional 333,855 shares during the period. Finally, Nuance Investments LLC increased its position in Henry Schein by 28.5% in the 1st quarter. Nuance Investments LLC now owns 1,755,190 shares of the company’s stock valued at $132,552,000 after acquiring an additional 388,843 shares during the period. 96.62% of the stock is currently owned by institutional investors and hedge funds.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.